TP53 and cancer: Since p73 can induce apoptosis independent of p53, and p73 is rarely mutated in cancers, elucidation of p73-dependent cell death pathways in response to chemotherapies may lead to the identification of novel drug targets for tumors with or without p53 aberrations [40].